MAM
TECH icon

Marquette Asset Management’s Bio-Techne TECH Stock Holding History

Marquette Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Buy
+21
New +$1.13K ﹤0.01% 671
2022
Q3 		– Sell
-4
Closed – – 379
2022
Q2 		$0 Buy
+4
New +$375 ﹤0.01% 422

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marquette Asset Management's TECH Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Bio-Techne (TECH) in Q2 2026: 21 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #671 among its holdings. This is a return to the name: Marquette Asset Management previously reported a position in TECH as recently as Q2 2022.

Marquette Asset Management first reported a position in TECH in Q2 2022 and has held it in 2 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Marquette Asset Management held 21 shares of Bio-Techne worth $1.48K as of Q2 2026.
  • Bio-Techne was a new Marquette Asset Management position in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #671 holding.
  • Marquette Asset Management first reported a position in Bio-Techne in Q2 2022 and has held it in 2 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.